& Company, Inc. Recalls Vivactil 5 mg Tablets
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
July 7, 1999
West Point, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Merck & Company, Inc. is recalling Vivactil 5
mg Tablets because of subpotency (stability).
Vivactil 5 mg Tablets (Protiptyline HCl), in bottles
of 100, Rx indicated for the treatment of symptoms of mental depression, particularly for
withdrawn and anergic patients. NDC #0006-0026-68.
LOT NOS. A7302 EXP 7/99, B6484 EXP 7/99, B5808 EXP 1/00, B8983 EXP 1/00, B8983SA EXP 1/00,
D5744 EXP 1/01,D5039 EXP 4/01, and E6209 EXP 10/01.
Merck & Company, Inc., West Point, Pennsylvania.
Manufacturer, by letter on May 17, 1999. Firm-initiated recall ongoing.
Firm estimated that 1,000 units remained at wholesale level at time of recall initiation.